Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 136
11
Diseases
6
Unique genes
0.383
Avg. similarity score
Deafness, onychodystrophy, osteodystrophy, impaired intellectual development, and seizures syndrome
Most-connected disease (9 links)
Disease
Searched: Epilepsy, rolandic, with paroxysmal exercise-induce dystonia and writer's cramp
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Epilepsy, rolandic, with paroxysmal exercise-induce dystonia and writer's cramp
Deafness, onychodystrophy, osteodystrophy, impaired intellectual development, and seizures syndrome
Focal epilepsy-intellectual disability-cerebro-cerebellar malformation
Deafness with congenital onychodystrophy
Deafness, autosomal dominant 65
Deafness, autosomal recessive 86
Digitrenocerebral syndrome
Doors syndrome
Infantile myoclonic epilepsy
Deafness-onychodystrophy syndrome
Periodic paralysis
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Deafness, onychodystrophy, osteodystrophy, impaired intellectual development, and seizures syndrome | 9 | 9 | 1 |
| Epilepsy, rolandic, with paroxysmal exercise-induce dystonia and writer's cramp | 9 | 9 | 1 |
| Focal epilepsy-intellectual disability-cerebro-cerebellar malformation | 9 | 9 | 1 |
| Deafness with congenital onychodystrophy | 8 | 8 | 2 |
| Deafness, autosomal dominant 65 | 6 | 6 | 1 |
| Deafness, autosomal recessive 86 | 6 | 6 | 1 |
| Digitrenocerebral syndrome | 6 | 6 | 3 |
| Doors syndrome | 6 | 6 | 2 |
| Infantile myoclonic epilepsy | 5 | 5 | 2 |
| Deafness-onychodystrophy syndrome | 3 | 3 | 1 |
| Periodic paralysis | 3 | 3 | 3 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| TBC1D24 | 10 / 11 | Deafness with congenital onychodystrophy, Deafness, autosomal dominant 65, Deafness, autosomal recessive 86, Deafness, onychodystrophy, osteodystrophy, impaired intellectual development, and seizures syndrome and 6 more |
| ATP6V1B2 | 4 / 11 | Deafness with congenital onychodystrophy, Deafness-onychodystrophy syndrome, Digitrenocerebral syndrome, Doors syndrome |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Synaptic vesicle cycle | KEGG | 3 / 79 | 76.0× | 5.40e-6 | 1.75e-4 ✓ sig. |
| Oxidative phosphorylation | KEGG | 3 / 137 | 43.8× | 2.83e-5 | 6.91e-4 ✓ sig. |
| Ion channel transport | Reactome | 2 / 24 | 167× | 5.71e-5 | 1.21e-3 ✓ sig. |
| Insulin receptor recycling | Reactome | 2 / 26 | 154× | 6.72e-5 | 1.38e-3 ✓ sig. |
| Collecting duct acid secretion | KEGG | 2 / 28 | 143× | 7.82e-5 | 1.56e-3 ✓ sig. |
| Transferrin endocytosis and recycling | Reactome | 2 / 31 | 129× | 9.61e-5 | 1.84e-3 ✓ sig. |
| ROS and RNS production in phagocytes | Reactome | 2 / 34 | 118× | 1.16e-4 | 2.13e-3 ✓ sig. |
| Vibrio cholerae infection | KEGG | 2 / 51 | 78.5× | 2.62e-4 | 4.06e-3 ✓ sig. |
| Amino acids regulate mTORC1 | Reactome | 2 / 55 | 72.8× | 3.05e-4 | 4.57e-3 ✓ sig. |
| Epithelial cell signaling in Helicobacter pylori infection | KEGG | 2 / 71 | 56.4× | 5.09e-4 | 6.76e-3 ✓ sig. |
| Rheumatoid arthritis | KEGG | 2 / 95 | 42.1× | 9.10e-4 | 1.06e-2 ✓ sig. |
| Classical Kir channels | Reactome | 1 / 4 | 500× | 2.00e-3 | 1.90e-2 ✓ sig. |
| Phagosome | KEGG | 2 / 155 | 25.8× | 2.40e-3 | 2.18e-2 ✓ sig. |
| mTOR signaling pathway | KEGG | 2 / 158 | 25.3× | 2.49e-3 | 2.23e-2 ✓ sig. |
| GABA synthesis, release, reuptake and degradation | Reactome | 1 / 13 | 154× | 6.48e-3 | 4.32e-2 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| synaptic vesicle lumen acidification | GO:0097401 | 2 / 18 | 346× | 1.31e-5 | 6.71e-4 ✓ sig. |
| proton transmembrane transport | GO:1902600 | 3 / 181 | 51.6× | 1.75e-5 | 8.35e-4 ✓ sig. |
| monoatomic ion transport | GO:0006811 | 4 / 667 | 18.7× | 2.28e-5 | 1.02e-3 ✓ sig. |
| regulation of macroautophagy | GO:0016241 | 2 / 57 | 109× | 1.36e-4 | 3.85e-3 ✓ sig. |
| regulation of skeletal muscle contraction via regulation of action potential | GO:0014861 | 1 / 1 | 3,115× | 3.21e-4 | 7.04e-3 ✓ sig. |
| regulation of exocytic insertion of neurotransmitter receptor to postsynaptic membrane | GO:0099145 | 1 / 1 | 3,115× | 3.21e-4 | 7.04e-3 ✓ sig. |
| cardiac muscle cell action potential | GO:0086001 | 1 / 3 | 1,038× | 9.63e-4 | 1.42e-2 ✓ sig. |
| relaxation of skeletal muscle | GO:0090076 | 1 / 3 | 1,038× | 9.63e-4 | 1.42e-2 ✓ sig. |
| negative regulation of cellular response to oxidative stress | GO:1900408 | 1 / 5 | 623× | 1.60e-3 | 1.88e-2 ✓ sig. |
| regulation of synaptic vesicle fusion to presynaptic active zone membrane | GO:0031630 | 1 / 7 | 445× | 2.25e-3 | 2.24e-2 ✓ sig. |
| membrane repolarization during action potential | GO:0086011 | 1 / 10 | 311× | 3.21e-3 | 2.69e-2 ✓ sig. |
| membrane repolarization during cardiac muscle cell action potential | GO:0086013 | 1 / 10 | 311× | 3.21e-3 | 2.69e-2 ✓ sig. |
| membrane depolarization during cardiac muscle cell action potential | GO:0086012 | 1 / 12 | 260× | 3.85e-3 | 2.94e-2 ✓ sig. |
| relaxation of cardiac muscle | GO:0055119 | 1 / 13 | 240× | 4.17e-3 | 3.06e-2 ✓ sig. |
| regulation of resting membrane potential | GO:0060075 | 1 / 13 | 240× | 4.17e-3 | 3.06e-2 ✓ sig. |